Simon X Benito insider trades
Open-market stock purchases and sales by Simon X Benito, Director at Inovio Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 16, 2010.
Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +13%.